| Dr Aubrey Jackson Evans, MD | |
|
1 Medical Park Blvd, Bristol, TN 37620-7430 | |
| (423) 844-1121 | |
| Not Available |
| Full Name | Dr Aubrey Jackson Evans |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 22 Years |
| Location | 1 Medical Park Blvd, Bristol, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538389200 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 2007-00590 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doctors Hospital Of Laredo | Laredo, TX | Hospital |
| Indian Path Community Hospital | Kingsport, TN | Hospital |
| Wellmont Holston Valley Medical Center | Kingsport, TN | Hospital |
| Wellmont Bristol Regional Medical Center | Bristol, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Laredo Physicians Group | 1355582461 | 31 |
| Wellmont Medical Associates Inc | 8123291739 | 405 |
News Archive
It's in the nature of presidential candidates and new presidents to promise big things. Just months after his 1961 inauguration, President John F. Kennedy vowed to send a man to the moon by the end of the decade.
Neuroscientists at Goethe University Frankfurt and the Max Planck Institute for Dynamics and Self-Organization in Göttingen have now discovered that certain areas of the brain generate less information when under anesthetic.
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that dosing has begun in its Phase IIa clinical study of its investigational compound IW-3718 in patients suffering from gastroesophageal reflux disease (GERD) who have not responded adequately to treatment with a proton pump inhibitor (PPI). Data are expected in the first half of 2015.
A preliminary study lends support to the hypothesis that a false-positive noninvasive prenatal test finding could be due to the presence of an occult maternal cancer.
› Verified 8 days ago
| Entity Name | Laredo Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659619260 PECOS PAC ID: 1355582461 Enrollment ID: O20130731000645 |
News Archive
It's in the nature of presidential candidates and new presidents to promise big things. Just months after his 1961 inauguration, President John F. Kennedy vowed to send a man to the moon by the end of the decade.
Neuroscientists at Goethe University Frankfurt and the Max Planck Institute for Dynamics and Self-Organization in Göttingen have now discovered that certain areas of the brain generate less information when under anesthetic.
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that dosing has begun in its Phase IIa clinical study of its investigational compound IW-3718 in patients suffering from gastroesophageal reflux disease (GERD) who have not responded adequately to treatment with a proton pump inhibitor (PPI). Data are expected in the first half of 2015.
A preliminary study lends support to the hypothesis that a false-positive noninvasive prenatal test finding could be due to the presence of an occult maternal cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aubrey Jackson Evans, MD 1021 W Oakland Ave Ste 310, Johnson City, TN 37604-2192 Ph: (423) 302-6565 | Dr Aubrey Jackson Evans, MD 1 Medical Park Blvd, Bristol, TN 37620-7430 Ph: (423) 844-1121 |
News Archive
It's in the nature of presidential candidates and new presidents to promise big things. Just months after his 1961 inauguration, President John F. Kennedy vowed to send a man to the moon by the end of the decade.
Neuroscientists at Goethe University Frankfurt and the Max Planck Institute for Dynamics and Self-Organization in Göttingen have now discovered that certain areas of the brain generate less information when under anesthetic.
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that dosing has begun in its Phase IIa clinical study of its investigational compound IW-3718 in patients suffering from gastroesophageal reflux disease (GERD) who have not responded adequately to treatment with a proton pump inhibitor (PPI). Data are expected in the first half of 2015.
A preliminary study lends support to the hypothesis that a false-positive noninvasive prenatal test finding could be due to the presence of an occult maternal cancer.
› Verified 8 days ago
Dr. John W Coursey, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd, Bristol, TN 37620 Phone: 423-844-1121 | |
Dr. Santosh Shanmuga, MD Urology Medicare: Medicare Enrolled Practice Location: 1 Medical Park Blvd, Bristol, TN 37620 Phone: 423-844-1121 | |
Parrish F Moree, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 350 Steeles Rd, Ste 1, Bristol, TN 37620 Phone: 423-844-6600 Fax: 423-968-1255 | |
John Maxwell White Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd, Bristol, TN 37620 Phone: 423-844-1121 | |
Dr. Trisha Juliano Kammann, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd, Bristol, TN 37620 Phone: 423-844-1211 | |
Dr. John G. Griffith, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 28 Midway St, Suite 105, Bristol, TN 37620 Phone: 423-573-8100 Fax: 423-573-8102 |